BenevolentAI
Kenny Claes is an experienced Big Data Architect at BenevolentAI since September 2015 and the Founder of Ardaco VOF since July 2015. Previously, Kenny held the position of Software Architect at Continuum Consulting nv from October 2008 to October 2015 and at Ordina Belgium from July 2006 to September 2008. Early career experience includes Senior Software Engineer at Real Software from February 2006 to July 2006 and Software Engineer at Inventive Designers from July 2001 to January 2006. Kenny Claes obtained a Master of Computer Science from the University of Antwerp between 1997 and 2001 and is currently pursuing Academic Teacher Training at the same institution.
This person is not in any teams
This person is not in any offices
BenevolentAI
8 followers
BenevolentAI combines advanced AI and machine learning with cutting edge science to decipher complex disease biology, generate novel insights and discover more effective medicines. Our unique computational R&D platform spans every step of the drug discovery process, powering an in-house pipeline of 25+ drug programmes from early discovery towards clinical phases. With several successful collaborations with leading pharmaceutical organisations, we are also the only AI-drug discovery company with a clinically validated approach, discovering a leading repurposed drug candidate for COVID-19. BenevolentAI is headquartered in London with a research facility in Cambridge (UK) and a further office in New York, with a team of over 300 world-leading scientists and technologists progressing its mission to reinvent drug discovery and advance life-changing drugs through to the clinic.